Skip to main content
SpringerLink
Log in

Combined chemotherapy and radiotherapy in small-cell lung cancer

  • Chapter
Book cover New Drugs, Concepts and Results in Cancer Chemotherapy

Part of the book series: Cancer Treatment and Research ((CTAR,volume 58))

Abstract

Although known to be one of the most chemoresponsive and radiosensitive solid tumors in adult patients, small-cell lung carcinoma (SCLC) still has a particularly poor prognosis, with a 2-year survival not exceeding 10% in most series [1–4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davis S, Wright PW, Schulman SF, Scholes D, Thorning D, and Hammar S. Long-term survival in small cell carcinoma of the lung: a population experience. J Clin Oncol 3:80–91, 1985.

    PubMed  CAS  Google Scholar 

  2. Hansen M, Hansen HH, and Dombernowsky P. Long-term survival in small cell carcinoma of the lung. JAMA 244:247–250, 1980.

    Article  PubMed  CAS  Google Scholar 

  3. Lee JS, Unsawasdi T, Lee Y, Barkley HT, Murphy WK, Welch S, and Valdivieso M. Neurotoxicity in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 12:313–321, 1984.

    Google Scholar 

  4. Souhami RL, Geddes DM, Spiro SG, Harper PG, Tobias JS, Mantell BS, Fearon F, and Bradbury I. Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial. Br Med J 288:1643–1646, 1984.

    Article  CAS  Google Scholar 

  5. Maurer LH and Pajak TF. Prognostic factors in small cell carcinoma of the lung: a Cancer and Leukemia Group B study. Cancer Treat Rep 65:767–774, 1981.

    PubMed  CAS  Google Scholar 

  6. Harper PG, Souhami RL, Spiro SG, Geddes DM, Guimaraes M, Fearon F, and Smyth JF. Tumor size, response rate and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy. Cancer Treat Rep 66:463–470, 1982.

    PubMed  CAS  Google Scholar 

  7. Osterlind K, Hansen HH, Hansen M, Dombernowsky P, and Andersen PK. Long-term disease-free survival in small-cell carcinoma of the lung: a study of clinical determinants. J Clin Oncol 4:1307–1313, 1986.

    PubMed  CAS  Google Scholar 

  8. Tubiana M, Arriagada R, Carde P, Cosset JM, and Le Chevalier T. Adjuvant radiotherapy in chemosensitive tumors. In: Adjuvant Therapy of Cancer V, SE Salmon (ed). Grune & Stratton, Orlando, pp. 25–34.

    Google Scholar 

  9. Choi NC, Propert K, Carey RW, Eaton W, Leone LA, Silberfarb P, and Green M. Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II study of Cancer and Leukemia Group B. Int J Radiat Oncol Biol Phys 13:263–266, 1987.

    Article  PubMed  CAS  Google Scholar 

  10. Rubin P. Late effects of chemotherapy and radiation therapy: a new hypothesis. Int J Radiat Oncol Biol Phys 19:5–34, 1984.

    Google Scholar 

  11. Lagrange JL, Thyss A, Caldani C, Hery M, Schneider M, and Bensadoun JR. Toxicity of combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin disease patients with massive initial mediastinal involvement. Bull Cancer 75:801–806, 1988.

    PubMed  CAS  Google Scholar 

  12. Tubiana M, Arriagada R, and Cosset JM. Sequencing of drugs and radiation. Cancer 55:2131–2139, 1985.

    Article  PubMed  CAS  Google Scholar 

  13. Fu KK. Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer 55:2123–2130, 1985.

    Article  PubMed  CAS  Google Scholar 

  14. Von Der Maase H. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumor. Radiother Oncol 7:47–68, 1986.

    Article  PubMed  Google Scholar 

  15. Steel GC. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 11:31–53, 1988.

    Article  PubMed  CAS  Google Scholar 

  16. Tubiana M. Les associations radiothérapie-chimiothérapie. Bull Cancer 68:109–115, 1981.

    PubMed  CAS  Google Scholar 

  17. Looney WB and Hopkins HA. Alternation of chemotherapy and radiotherapy in cancer management. III. Results in experimental solid tumors systems and their relationship to clinical studies. Cancer Treat Rep 70:141–162, 1986.

    PubMed  CAS  Google Scholar 

  18. Tubiana M. Repopulation in human tumors. A biological background for fractionation in radiotherapy. Acta Oncol 27:83–88, 1988.

    Article  PubMed  CAS  Google Scholar 

  19. Withers HR, Taylor JMG, and Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131–146, 1988.

    Article  PubMed  CAS  Google Scholar 

  20. Schimke RT. Methotrexate resistance and gene amplification. Mechanisms and implications. In: Accomplishments in Cancer Research, JG Fortner and JE Rhoads (eds), JB Lippincott, Philadelphia, 1986, pp. 75.

    Google Scholar 

  21. Louie KG, Behrens BC, Kinsella TJ, Hamilton TC, Grotzinger KR, McKoy WM, Winker MA, and Ozols RF. Radiation survival parameters of antineoplastic drug-sensitive and resistant human ovarian cancer cell lines and their modification by buthionine. Cancer Res 45:2110–2115, 1985.

    PubMed  CAS  Google Scholar 

  22. Mitchell JB, Gamson J, Russo A, Friedman N, Degraff W, Carmichael J, and Glatstein E. Chinese hamster pleiotropic multidrug resistant cells are not radioresistant. NCI Monogr 6:187–191, 1988.

    PubMed  Google Scholar 

  23. Wallner K and Li GC. Adriamycin resistance, heat resistance and radiation response in Chinese hamster fibroblasts. Int J Rad Oncol Biol Phys 12:829–833, 1986.

    Article  CAS  Google Scholar 

  24. Goldie GH and Coldman AG. The genetic origin of drug resistance in neoplasm: implications for systemic therapy. Cancer Res 44:3643–3663, 1984.

    PubMed  CAS  Google Scholar 

  25. Fox RM, Woods RL, Brodie GN, and Tattersall MHN. A randomized study: small cell anaplastic lung cancer treated by combination chemotherapy and adjuvant radiotherapy. Int J Rad Oncol Biol Phys 6:1083–1085, 1980.

    Article  CAS  Google Scholar 

  26. Kies MS, Mira JG, Crowley JJ, Chen TT, Pazdur R, Grozea PN, Rivkin SE, Coltman CA, Ward JH, and Livingston RB. Multimodal therapy for limited small cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide field versus reduced field radiation in partial responders: a Southwest Oncology Group study. J Clin Oncol 5:592–600, 1987.

    PubMed  CAS  Google Scholar 

  27. Creech R, Richter M, and Finkelstein D, for the ECOG. Combination chemotherapy with or without consolidation radiation therapy (RT) for regional small cell carcinoma of the lung. Proc Am Soc Clin Oncol, abstract 756, 1988.

    Google Scholar 

  28. Osterlind K, Hansen HH, Hansen HS, Dombernovsky P, Hansen M, and Rorth M. Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer: results of a controlled trial with 5 years’ follow-up. Br J Cancer 54:7–17, 1986.

    Article  PubMed  CAS  Google Scholar 

  29. Bunn PA, Lichter AS, Makuch RW, Cohen MH, Veach SR, Matthews MJ, Johnston-Anderson A, Edison M, Glatstein E, Minna JD, and Ihde DC. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer: a prospective randomized trial. Ann Intern Med 106:655–662, 1987.

    PubMed  Google Scholar 

  30. Perry MC, Eaton WL, Propert KJ, Ware JH, Zimmer B, Chahinian AP, Skarin A, Carey RW, Kreisman H, Faulkner C, Comis R, and Green MR. Chemotherapy with or without radiation therapy in limited small cell carcinoma of the lung. N Engl J Med 316:912–918, 1987.

    Article  PubMed  CAS  Google Scholar 

  31. Perez CA, Einhorn L, Oldham RK, Greco FA, Cohen HJ, Silerman H, Krauss S, Hornback N, Comas F, Omura G, Salter M, Keller JW, McLaren J, Kellermeyer R, Storaasli J, Birch R, and Dandy M. Randomized trial of radiotherapy to the thorax in limited small cell a preliminary report. J Clin Oncol 2:1200–1208, 1984.

    PubMed  CAS  Google Scholar 

  32. Looney WB, Special lecture: alternating chemotherapy and radiotherapy. NCI Monogr 6:85–94, 1988.

    PubMed  Google Scholar 

  33. Arriagada R, Le Chevalier T, Baldeyrou P, Pico JL, Ruffie P, Martin M, El Bakry HM, Duroux P, Bignon J, Lenfant B, Hayat M, Rouesse JG, Sancho-Garnier H, and Tubiana M. Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease. Int J Rad Oncol Biol Phys 11:1461–1467, 1985.

    Article  CAS  Google Scholar 

  34. Pico JL, Le Chevalier T, Baume D, Arriagada R, Beaujan F, and Hayat M. Phase I-II study of high dose chemotherapy (HDC) followed by autologous bone marrow transplantation (ABMT) in small cell lung cancer. European Society for Medical Oncology. Nice, November 28–30, 1986, abstract no. 225, 1986.

    Google Scholar 

  35. World Health Organization. Handbook for Reporting the Results of Cancer Treatment. WHO Offset, Publ. no. 48. World Health Organization, Geneva.

    Google Scholar 

  36. Cox DR. Regression models and life tables. J R Stat Soc 34:187–220, 1972.

    Google Scholar 

  37. Le Chevalier T, Arriagada R, De The H, De Cremoux H, Sancho-Garnier H, and Rouesse J. Toxicity of first chemotherapy cycle as major prognostic factor in survival of patients with limited small cell lung cancer (LSCLC). Proc Am Soc Clin Oncol 5:181, 1986.

    Google Scholar 

  38. Arriagada R, De The H, Thomas F, Ruffie P, De Cremoux H, Martin M, Duroux P, Dewar J, Sancho-Garnier H, and Le Chevalier T. Limited small cell lung cancer: a possible prognostic impact of initial chemotherapy doses. Bull Cancer 76:605–615, 1989.

    Google Scholar 

  39. Le Chevalier T, Arriagada R, De The H, De Cremoux H, Martin M, Baldeyrou P, Ruffie P, Benna F, Cerrina ML, Sancho-Garnier H, and Hayat M. Combination of chemotherapy and radiotherapy in limited small cel lung carcinoma: results of alternating schedule in 109 patients. NCI Monogr 6:335–338, 1988.

    PubMed  Google Scholar 

  40. De Cremoux H, Baldeyrou P, Martin M, Ruffie P, Arriagada R, and Le Chevalier T. Late pulmonary toxicity of alternating radiotherapy (RT) and chemotherapy (CT) in limited small cell lung cancer (SCLC). Role of VP 16. Proc Am Soc Clin Oncol, abstract 709,1987.

    Google Scholar 

  41. Johnson BE, Ihde DC, Bunn PA, Becker B, Walsh T, Weinstein ZR, Matthews MJ, Whang-Peng J, Makuch RW, Johnston-Early A, Lichter AS, Carney DN, Cohen MH, Glatstein E, and Minna JD. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Ann Intern Med 103:430–438, 1985.

    PubMed  CAS  Google Scholar 

  42. Henry-Amar M. Quantitative risk of second cancer in patients in first complete remission for early stages of Hodgkin’s disease. NCI Monogr 6:65–72, 1988.

    PubMed  Google Scholar 

  43. Turrisi AT, Glover DJ, and Mason BA. Concurrent twice-daily radiotherapy plus platinumetoposide chemotherapy for the treatment of limited small cell lung cancer: a preliminary report. In: Treatments Modalities in Lung Cancer, Antibiotics and Chemotherapy, Vol. 41, R Arriagada, and T Le Chevalier (eds). S. Karger, Basel, 1988, pp. 109–114.

    Google Scholar 

Download references

Authors
  1. Thierry Le Chevalier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodrigo Arriagada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maurice Tubiana
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Southern California Cancer Center, USA

    F. M. Muggia

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Kluwer Academic Publishers, Boston.

About this chapter

Cite this chapter

Chevalier, T.L., Arriagada, R., Tubiana, M. (1992). Combined chemotherapy and radiotherapy in small-cell lung cancer. In: Muggia, F.M. (eds) New Drugs, Concepts and Results in Cancer Chemotherapy. Cancer Treatment and Research, vol 58. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3876-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3876-9_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-7923-1253-6

  • Online ISBN: 978-1-4615-3876-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation